4- amino- 2- (butyrylamino)phenyl(2E,4E,6E,8E)- 3,7- dimethyl- 9- (2,6,6- trimethyl- 1- cyclohexenyl)- 2,4,6,8- nonatetraenoate

a retinoic acid derivative ABPN has potent inhibitory activity on cell growth and apoptosis in cancer cells

Also Known As:

ABPN cpd; CBG41 cpd

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Colonic Neoplasms (Colon Cancer) 12/20/2003 - "In an initial screening of these synthetic retinoids using the HCT116 colon cancer cell line, we found that 4-amino-2-(butyrylamino)phenyl(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-2,4,6,8-nonatetraenoate (ABPN or CBG41) induced the greatest growth inhibition, with an IC(50) value of 0.6 microM. "

1.	Retinoids